Today: May 28, 2018, 5:29 am
  
Business

Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference

PR-Inside.com: 2018-01-03 22:06:02

DUBLIN, Ireland, Jan. 3, 2018 - Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience and orphan categories, today announced that members of its senior management team will present and participate in the 36th Annual J.P. Morgan Healthcare Conference on January 10th at 8:30 AM PT in San Francisco, CA. 

A live webcast of the company presentation can be accessed through the Investors section of the Company's website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company's website for at least 90 days following the presentation date.

About Prothena

Prothena Corporation plc is a global, late-stage clinical biotechnology company establishing fully integrated research, development and commercial capabilities and focused on advancing new therapies in the neuroscience and orphan categories. Fueled by its deep scientific understanding built over decades of research in protein misfolding, Prothena seeks to fundamentally change the course of grave or currently untreatable diseases associated with this biology. Prothena's pipeline of antibody therapeutic candidates targets a number of indications including AL amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002/RG7935) and ATTR amyloidosis (PRX004). The Company continues discovery of additional novel therapeutic candidates where its deep scientific understanding of disease pathology can be leveraged. For more information, please visit the Company's website at www.prothena.com.

Media & Investor Contact:

Ellen Rose, Head of Communications

650-922-2405, ellen.rose@prothena.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Prothena Corporation plc via Globenewswire




# 403 Words
Related Articles
More From The Author
Celebrate the Year of the Dog at [..]
Players at Australia’s favourite online casino, FairGoCasino.com : 2018 is the Year of the Dog, and Fu Chi : The [..]
Aptean Expands Text Analytics Capabilities With TheySay [..]
ALPHARETTA, Ga., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Aptean, a leading global provider of mission-critical enterprise software solutions, [..]
United States Aircraft Insurance Group (USAIG) Celebrates [..]
New York, NY, Jan. 03, 2018 (GLOBE NEWSWIRE) -- On July 1, 2018 USAIG will mark 90 years as a [..]
Microglue of Mexico SRL to become Valco [..]
Valco Melton recently announced that as of December 1, 2017 its Mexico office, formerly known as Microglue de Mexico, made [..]
Bombardier to Provide 54 Additional TWINDEXX Vario [..]
Bombardier Transportation / Bombardier to Provide 54 Additional TWINDEXX Vario Double-Deck Coaches to Israel Railways . Processed [..]
 
More From Business
Tarps Now® Announces Expanded Offers of Sun [..]
ST. JOSEPH, MICHIGAN, UNITED STATES -- Tarps Now® has released a greatly expanded line of outdoor Mesh Sun Shade Tarps [..]
G2H2 Capital Makes a Purchase on the [..]
HONG KONG, May 24, 2018 - (ACN Newswire) - G2H2 Capital ("G2H2") signed an agreement with AnApp Blockchain Technologies Limited [..]
Oppenheimer Europe CEO Max Lami On Course [..]
Oppenheimer Europe CEO Max Lami On Course With M&A Business Expansion Plan, Four Years On Nearly four years have passed [..]
AnApp announces the birth of an innovative [..]
HONG KONG, May 21, 2018 - (ACN Newswire) - AnApp Blockchain Technologies Limited ("AnApp") announces the development of [..]
HKTDC Entrepreneur Day 2018 Opens
Most International and Tech-focused Edition Ever HONG KONG, May 17, 2018 - (ACN Newswire) - A record 276 exhibitors are [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.